Acetyl-L-Carnitine for the Treatment of NRTI-Associated Peripheral Neuropathy

NACompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

Not specified

Study Completion Date

January 31, 2007

Conditions
HIV InfectionsPeripheral Nervous System Diseases
Interventions
DRUG

Acetyl-L-carnitine

Trial Locations (11)

10003

Beth Israel Med. Ctr., ACTU, New York

30308

The Ponce de Leon Ctr. CRS, Atlanta

60612

Cook County Hosp. CORE Ctr., Chicago

94305

Stanford CRS, Palo Alto

Unknown

Univ. of Hawaii at Manoa, Leahi Hosp., Honolulu

Weill Med. College of Cornell Univ., The Cornell CTU, New York

60611-3015

Northwestern University CRS, Chicago

21287-8106

Johns Hopkins Adult AIDS CRS, Baltimore

63108-2138

Washington U CRS, St Louis

90033-1079

University of Washington AIDS CRS, Seattle

00936-5067

Puerto Rico-AIDS CRS, San Juan

All Listed Sponsors
collaborator

Neurologic AIDS Research Consortium (NARC)

OTHER

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00050271 - Acetyl-L-Carnitine for the Treatment of NRTI-Associated Peripheral Neuropathy | Biotech Hunter | Biotech Hunter